When Others Are Fearful, Buy Hewlett Packard

To be perfectly blunt, Hewlett-Packard Co. (HPQ) posted a solid first quarter 2011 (see conference call transcript here). However, it’s amazing how the media can spin a tale of negativity out of excellent operating results, and how the market could take this already inexpensive technology stalwart down at a double-digit percentage rate as a result. Read more about When Others Are Fearful, Buy Hewlett Packard[…]

A Primer on Valuation: 9 Very Fast-Growing Super Stocks

Introduction This article is going to deal with growth stocks and how to value them. First of all, it’s important to point out that growth stocks are very different than ordinary stocks. Growth stocks need to be thought about differently, because they possess powerful attributes that their more ordinary cousins do not. Even though this Read more about A Primer on Valuation: 9 Very Fast-Growing Super Stocks[…]

A Primer on Valuation: 8 Examples of How Earnings Growth Drives Dividends and Returns

Valuation Based on Fundamentals In order to prudently answer the question of when to buy a stock, an investor first needs to know the value of the company behind the stock. At the most basic level, a company derives its value based on the fundamentals behind the business it operates. Focusing on, and calculating the Read more about A Primer on Valuation: 8 Examples of How Earnings Growth Drives Dividends and Returns[…]

A Primer on Valuation: Testing the Wisdom of Ben Graham’s Formula

If an investor is going to successfully invest in common stocks over their lifetime, there are three important questions that must be correctly answered. What to invest in? When to invest? When to sell? The first question deals with finding the right company or companies that you believe can deliver the returns you are seeking. Read more about A Primer on Valuation: Testing the Wisdom of Ben Graham’s Formula[…]

Ben Graham’s Stock Valuing Formula: It Really Works

Ben Graham’s famed formula for valuing a stock works in the real world! V* = EPS x (8.5 + 2g) Ten Real World examples of companies growing between zero and 5% These ten examples are based on our article: “A primer on valuation: Testing the Wisdom of Ben Graham’s Formula” (part one) published on 2/08/2011. Read more about Ben Graham’s Stock Valuing Formula: It Really Works[…]

A Primer on Valuation: Testing the Wisdom of Ben Graham’s Formula

If an investor is going to successfully invest in common stocks over their lifetime, there are three important questions that must be correctly answered. What to invest in? When to invest? When to sell? The first question deals with finding the right company or companies that you believe can deliver the returns you are seeking. Read more about A Primer on Valuation: Testing the Wisdom of Ben Graham’s Formula[…]

Hudson City Bancorp: Short-Term Risk, Long-Term Opportunity?

Hudson City Bancorp (HCBK) is widely recognized as one of the most conservatively and best managed financial institutions in the country. Thanks to their conservative lending practices and prudent fiscal management, Hudson City Bancorp prospered through the great recession while other financial institutions faltered and even collapsed. This prudently run financial institution did not partake Read more about Hudson City Bancorp: Short-Term Risk, Long-Term Opportunity?[…]

Would Ben Graham Give Warren Buffett an ‘F’ for Holding Coca-Cola?

As most everyone knows, Warren Buffett received much of his initial investing education from the father of modern security analysis, the venerable Ben Graham. Personally, I attribute most everything I know about investing from reading the teachings of both Graham and Buffett. To me, it only made sense to learn as much as I could Read more about Would Ben Graham Give Warren Buffett an ‘F’ for Holding Coca-Cola?[…]

Teva Pharmaceutical Has It All: Value, Growth and Yield

Headquartered in Israel, Teva (TEVA) is the world’s largest generic drug maker, which markets over 1200 molecules in over 60 countries throughout the world. In addition to their generic portfolio, Teva also possesses a strong branded portfolio led by Copaxone, the world’s leading injectable therapy for multiple sclerosis. Teva generates high levels of cash flow, Read more about Teva Pharmaceutical Has It All: Value, Growth and Yield[…]

6 High Yield Pharmaceutical Companies: Do They Justify the Risk?

Introduction Today Investors are keenly focused on income while simultaneously very risk averse.This current behavior brings with it a level of frustration.The appetite for yield is high precisely at a time when yields on the traditionally safest investments like bonds and CDs, etc. are at historic lows.On the other hand, dividend yields on many blue-chip Read more about 6 High Yield Pharmaceutical Companies: Do They Justify the Risk?[…]